Acute Tolerance to Subjective but not Cardiovascular Effects of 4-Amphetamine in Normal, Healthy Men

Journal of Clinical Psychopharmacology

Volumn 16, Issue 1, 1996, Pages 72-76

  Brauer, Lisa H ^a,c   Ambre, John ^b   De Wit, Harriet ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b AMERICAN MEDICAL ASSOCIATION   (United States)

^c DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMPHETAMINE;

ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; DRUG BLOOD LEVEL; DRUG TOLERANCE; HEART RATE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACODYNAMICS; PHARMACOKINETICS; PRIORITY JOURNAL;

ADULT; AFFECT; BLOOD PRESSURE; CENTRAL NERVOUS SYSTEM STIMULANTS; DEXTROAMPHETAMINE; DRUG TOLERANCE; HEART RATE; HEMODYNAMIC PROCESSES; HUMANS; MALE;

EID: 0030021302     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199602000-00012     Document Type: Article

References (23)

1. Dingemanse J, Danhof M, Breimer DD. Pharmacokinetic-pharmacodynamic modeling of CNS drug effects: an overview. Pharmacol Ther 1988;38:1-52.
2. Foltin RW, Fischman MW. Assessment of abuse liability of stimulant drugs in humans: a methodological survey. Drug Alcohol Depend 1991;28:3-48.
3. Farre M, Cami J. Pharmacokinetic considerations in abuse liability evaluation. Br J Addict 1991;86:1601-6.
4. de Wit H, Bodker B, Ambre J. Rate of increase of plasma drug level influences subjective response in humans, Psychopharmacology 1992;107:352-8.
5. Javaid JI, Fischman MW, Schuster CR, Dekirmenjian H, Davis JM. Cocaine plasma concentration: relation to physiological and subjective effects in humans. Science 1978;292:227-8.
6. Fischman MW, Schuster CR, Javaid JI, Hatano Y, Davis JM. Acute tolerance development to the cardiovascular and subjective effects of cocaine. J Pharmacol Exp Ther 1985;235:667-82.
7. Ambre JJ, Belknap SM, Nelson J, Ruo TI, Shin S, Atkinson AJ. Acute tolerance to cocaine in humans. Clin Pharmacol Ther 1988;44:1-8.
8. Foltin RW, Fischman MW, Pedroso JJ, Pearlson Op. Repeated intranasal cocaine administration: lack of tolerance to pressor effects. Drug Alcohol Depend 1988;22:169-77.
9. Foltin RW, Fischman MW. The relationship between cocaine venous blood levels and the cardiovascular and subjective effects of smoked and intravenous cocaine. In Harris LS, ed. Problems of drug dependence 1990: proceedings of the 52nd Annual Scientific Meeting, Committee on Problems of Drug Dependence, Inc. Washington, DC: US Government Printing Office, 1990:440-1.
10. Ambre JJ. Acute tolerance to pressor effects of cocaine in humans. Ther Drug Monit 1993;15:537-40.
11. Brown WA, Corriveau DP, Ebert MH. Acute psychologic and neuroendocrine effects of dextroamphetamine and methylphenidate. Psychopharmacology 1978;58:189-95.
12. Dommisse CS, Schulz SC, Narasimhachari N, Blackard WG, Hamer RM. The neuroendocrine and behavioral response to dextroamphetamine in normal individuals. Biol Psychiatry 1984;19:1305-15.
13. Angrist B, Corwin J, Bartlik B, Cooper T. Early pharmacokinetics and clinical effects of oral d-amphetamine in normal subjects. Biol Psychiatry 1987;22:1357-68.
14. Yonkers KA, Kando JC, Cole JO, Blumenthal SB. Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medication. Am J Psychiatry 1992;149:587-95.
15. Brauer LH, de Wit H. Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers. Biol Psychiatry (in press).
16. McNair DM, Lorr M, Droppleman LF. Profile of mood states (manual). San Francisco: Educational and Industrial Testing Service, 1971.
17. Johanson CE, Uhlenhuth E. Drug preference and mood in humans: d-amphetamine. Psychopharmacology 1980;71:275-9.
18. Haertzen CA, Hill HE, Belleville RE. Development of the Addiction Research Center Inventory (ARCI): selection of items that are sensitive to the effects of various drugs. Psychopharmacology 1963;4:155-6.
19. Martin WR, Sloan JW, Sapira JD, Jasinski DR. Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 1971;12:245-57.
20. Fischman MW, Foltin RW. Utility of subjective-effects measurements in assessing abuse liability of drugs in humans. Br J Addict 1991;86:1563-70.
21. Wilkins D, Crouch D, Rollins D. Analysis of phenylpropanolamine by positive chemical ionization mass spectrometry [abstract K17]. Presented at the Annual Meeting of the American Academy of Forensic Science. Las Vegas, NV, 1989.
22. Elkins K, Gibb J, Hanson G, Wilkins D, Johnson M. Effects of nimodipine on the amphetamine- and methamphetamine-induced decrease in tryptophan hydroxylase activity. Eur J Pharmacol 1993;250:395-402.
23. Hoffman BB, Lefkowitz RJ. Catecholamines and sympathomimetic drugs. In Gilman AG, Rall TW, Nies AS, Taylor P, eds. The pharmacological basis of therapeutics. New York: Pergamon Press, 1990:187-220.